First, we identified a significant differential expression of HPSE in BRAF V600E-mutant CRC versus wild-type (including KRAS-mutant and KRAS/BRAF wild-type) CRC using integrated data, and performed survival analyses in a retrospective clinical cohort. Here, BRAF is linked to colorectal carcinoma.